Partnership
Partner with Alphanosos to discover and develop next-generation therapeutics and bioactive innovations powered by AI and natural biodiversity
- Research
- Business
- Franchising
- Joint development
CEO at Alphanosos
Riom, France
Drug discovery is slow, costly and risky. We use AI and experimental biology to discover natural bioactives faster and more efficiently. We serve pharma and consumer health companies with patented assets supported by preclinical and clinical validation.
Additional Information
Booth number at VivaTech 2026
3H21-001
CEO
Alphanosos
Partnership
Partner with Alphanosos to discover and develop next-generation therapeutics and bioactive innovations powered by AI and natural biodiversity
CEO at Alphanosos
Riom, France
Investment
Alphanosos seeks strategic and financial investors to accelerate the development of its AI-powered discovery platform, patented therapeutic assets, and growing portfolio of clinical and commercial opportunities.
CEO at Alphanosos
Riom, France
Project cooperation
Alphanosos seeks partners for collaborative R&D, clinical validation, and co-funded innovation projects leveraging its AI-driven discovery platform across health, consumer health, cosmetics, animal health, and sustainability applications.
CEO at Alphanosos
Riom, France